Economic Impact of Switchback from Generic to Brand-Name Drugs: Example of Allopurinol

被引：0
|
作者：
Laroche, M. L. [1 ]
Crepin, S. [1 ]
Deysson, M. [2 ]
Merle, L. [1 ]
机构：
[1] Reg Ctr Pharmacovigilance, Limoges, France
[2] Med Unit Reg Hlth Insurance, Limoges, France
来源：
DRUG SAFETY | 2009年 / 32卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
69
引用
收藏
页码：905 / 905
页数：1
相关论文
共 50 条
  • [31] Safety of Overnight Switch from Brand-Name to Generic Levetiracetam
    Maria Stella Vari
    Francesca Pinto
    Elisabetta Mencaroni
    Giovanna Giudizioso
    Carlo Minetti
    Angela La Neve
    Tiziana Francavilla
    Marta Piccioli
    Salvatore Striano
    Luigi del Gaudio
    Pierangelo Tovo
    Pasquale Striano
    Alberto Verrotti
    [J]. Clinical Drug Investigation, 2016, 36 : 87 - 91
  • [32] Converting patients from brand-name clozapine to generic clozapine
    Sajbel, TA
    Carter, GW
    Wiley, RB
    [J]. ANNALS OF PHARMACOTHERAPY, 2001, 35 (03) : 281 - 284
  • [33] Generic script share and the price of brand-name drugs: the role of consumer choice
    Rizzo, John A.
    Zeckhauser, Richard
    [J]. INTERNATIONAL JOURNAL OF HEALTH CARE FINANCE & ECONOMICS, 2009, 9 (03): : 291 - 316
  • [34] Plan Designs That Encourage the Use of Generic Drugs Over Brand-Name Drugs: An Analysis of a Free Generic Benefit
    Rodin, Holly A.
    Heaton, Alan H.
    Wilson, Amy R.
    Garrett, Nancy A.
    Plocher, David W.
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2009, 15 (12): : 881 - 888
  • [35] Generic script share and the price of brand-name drugs: the role of consumer choice
    John A. Rizzo
    Richard Zeckhauser
    [J]. International Journal of Health Care Finance and Economics, 2009, 9 : 291 - 316
  • [36] The population's perceptions of generic drugs compared to original brand-name drugs in Peruvian hospitals
    Mendoza-Chuctaya, Giuston
    Samir Cubas-Llalle, Wildor
    Mejia, Christian R.
    Emerson Chachaima-Mar, Jorge
    Montesinos-Segura, Renee
    Arce-Villalobos, Laura R.
    Carlos Mamani-Cruz, John
    [J]. CADERNOS DE SAUDE PUBLICA, 2019, 35 (10):
  • [37] The FDA's Generic-Drug Approval Process: Similarities to and Differences From Brand-Name Drugs
    Kefalas, Costas H.
    Ciociola, Arthur A.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 (06): : 1018 - 1021
  • [38] THE IMPACT OF GENERIC DRUG ENTRY ON MARKET SHARES AND PRICES OF BRAND-NAME DRUGS-EVIDENCE FROM CHINESE PHARMACEUTICAL MARKET
    Chen, J.
    Tian, Y.
    Shi, L. W.
    [J]. VALUE IN HEALTH, 2018, 21 : S9 - S9
  • [39] Safety of switching from brand-name to generic levetiracetam in patients with epilepsy
    Bosak, Magdalena
    Slowik, Agnieszka
    Turaj, Wojciech
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 2287 - 2291
  • [40] Comparison of the effectiveness of brand-name and generic antipsychotic drugs for treating patients with schizophrenia in Taiwan
    Hsu, Chih-Wei
    Lee, Sheng-Yu
    Wang, Liang-Jen
    [J]. SCHIZOPHRENIA RESEARCH, 2018, 193 : 107 - 113
12345